These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17259471)

  • 1. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
    Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
    Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transplant Proc; 2005 Mar; 37(2):1326-7. PubMed ID: 15848711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
    Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
    N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
    Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
    Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
    Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
    Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management.
    Leitão CB; Cure P; Messinger S; Pileggi A; Lenz O; Froud T; Faradji RN; Selvaggi G; Kupin W; Ricordi C; Alejandro R
    Transplantation; 2009 Mar; 87(5):681-8. PubMed ID: 19295312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
    Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
    Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
    Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
    Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
    Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
    Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.
    Turgeon NA; Avila JG; Cano JA; Hutchinson JJ; Badell IR; Page AJ; Adams AB; Sears MH; Bowen PH; Kirk AD; Pearson TC; Larsen CP
    Am J Transplant; 2010 Sep; 10(9):2082-91. PubMed ID: 20883542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
    Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
    Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.
    Warnock GL; Thompson DM; Meloche RM; Shapiro RJ; Ao Z; Keown P; Johnson JD; Verchere CB; Partovi N; Begg IS; Fung M; Kozak SE; Tong SO; Alghofaili KM; Harris C
    Transplantation; 2008 Dec; 86(12):1762-6. PubMed ID: 19104418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
    O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
    Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation.
    Fiorina P; Venturini M; Folli F; Losio C; Maffi P; Placidi C; La Rosa S; Orsenigo E; Socci C; Capella C; Del Maschio A; Secchi A
    Diabetes Care; 2005 Jun; 28(6):1303-10. PubMed ID: 15920043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.
    Toso C; Baertschiger R; Morel P; Bosco D; Armanet M; Wojtusciszyn A; Badet L; Philippe J; Becker CD; Hadaya K; Majno P; Bühler L; Berney T;
    Am J Transplant; 2006 May; 6(5 Pt 1):1049-58. PubMed ID: 16611343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up.
    Lehmann R; Weber M; Berthold P; Züllig R; Pfammatter T; Moritz W; Mädler K; Donath M; Ambühl P; Demartines N; Clavien And PA; Andreia Spinas G
    Am J Transplant; 2004 Jul; 4(7):1117-23. PubMed ID: 15196070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal decline in sirolimus elimination immediately after pancreatic islet transplantation.
    Sato E; Shimomura M; Masuda S; Yano I; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Inui K
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):492-500. PubMed ID: 17220565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
    Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
    Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction.
    Tan J; Yang S; Cai J; Guo J; Huang L; Wu Z; Chen J; Liao L
    Diabetes; 2008 Oct; 57(10):2666-71. PubMed ID: 18633105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.